Definium Therapeutics, Inc. (DFTX) — Capital Reinvestment Ratio
Latest as of June 2019:
0.00x
Definium Therapeutics, Inc. (DFTX) has a Capital Reinvestment Ratio of 0.00x as of June 2019, meaning it reinvests 0% of its operating cash flow ($24.19K) in capital expenditures ($0.11). Check Definium Therapeutics, Inc. tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$24.19K
USD
Capital Expenditures
$0.11
USD
Data as of
Jun 2019
Most recent filing
Annual Capital Reinvestment Ratio for Definium Therapeutics, Inc. (None–None)
Year-by-year Capital Reinvestment Ratio for Definium Therapeutics, Inc. from None to None. See Definium Therapeutics, Inc. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow